2-Chloro-4-bromoacetyl-thiazole → N-[2-(4-Carbomethoxymethoxyphenyl)-1-methylethyl]-2-hydroxy-2-(2-chloro-thiazol-4-yl)-morpholine

HRID 2210397Notes

Reaction equation

HRID 2210397 reaction equation
[C:1]([CH2:5][O:6][C:7]1[CH:12]=[CH:11][C:10]([CH2:13][CH:14]([NH:16][CH2:17][CH2:18][OH:19])[CH3:15])=[CH:9][CH:8]=1)([O:3][CH3:4])=[O:2].[Cl:20][C:21]1[S:22][CH:23]=[C:24]([C:26](=[O:29])[CH2:27]Br)[N:25]=1>>[C:1]([CH2:5][O:6][C:7]1[CH:12]=[CH:11][C:10]([CH2:13][CH:14]([N:16]2[CH2:17][CH2:18][O:19][C:26]([OH:29])([C:24]3[N:25]=[C:21]([Cl:20])[S:22][CH:23]=3)[CH2:27]2)[CH3:15])=[CH:9][CH:8]=1)([O:3][CH3:4])=[O:2]

Participants

3

Procedure

from N-[2-(4-carbomethoxymethoxyphenyl)-1-methylethyl]-2-hydroxy-ethanamine and 2-chloro-4-bromoacetyl-thiazole.

Sources & evidence

ORD record
ord-bb908d013a5442aba9a97ea32613de15
Source dataset
uspto-grants-1995_10
Patent number
US05457205

Reaction notes

Loading…